Neuroscience News Extended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely. Of 13 patients studied, five experienced sustained improvements, while others reported temporary or no benefits.
This complexity underscores the challenge of treating long Covid, a condition with over 200 symptoms ranging from brain fog to respiratory issues. Researchers emphasize the need for more targeted studies to determine which patients might benefit most from antiviral therapies.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.